As the COVID-19 vaccine roll out continues across Washington state, the United States and North America, we are interested in studying the COVID-19 vaccine in individuals who are pregnant, postpartum, lactating or planning pregnancy. Because pregnant and lactating individuals were excluded from the original clinical trials by the vaccine manufacturers, these studies will help to fill critical gaps in knowledge and provide information that will allow other pregnant and lactating individuals to make the best decision about COVID-19 vaccination for themselves.
In the face of increasing Anti-Asian violence and harassment, UW Department of OB/GYN stands firmly with the AAPI community as we continue our fight against racism, injustice, and white supremacy.
ACOG'S Practice Advisory Board was updated today to include information and recommendations regarding the newly authorized Janssen (Johnson & Johnson) vaccine, as well as safety data in pregnancy from CDC's v-safe and v-safe pregnancy registry.
Dr. Kristina Adams Waldorf is interviewed in Daily Mail about COVID-19 vaccines for pregnant women.
Dr. Emily Fay and Dr. Linda Eckert are interviewed in KUOW about COVID19 vaccines for pregnant women.
A scholar position in the University of Washington Women's Reproductive Health Research program will be available as soon as July 2021. Letters of Interest are due March 1st, 2021. Applications are due May 31st, 2021.
Dr. Kemi Doll appeared on Good Morning America to speak about her research focused on eliminating the racial mortality gap in endometrial cancer.
Here is a summary of UW Medicine COVID vaccine guidance for pregnant women.
Oral PrEP and type I interferon-like response may induce HIV protection and chronic immune activation.
Dr. Ginny Ryan is introduced to the UW community via a Q&A in The Huddle.
- 1 of 8
- next ›